New CEO Vas Narasimhan wants to cut Novartis' R&D costs by using digital tech – and with this in mind the firm has scaled up a project involving virtual clinical trials. The Swiss pharma company ...

Novartis’ head of drug development Vas Narasimhan talks about the company’s stake in CAR-T immunotherapy. These cell therapies are set to transform treatment of blood cancers – but questions ...

Silas Zindel—13PHOTO/Redux Early in Vas Narasimhan’s career as a physician scientist, he worked on programs for treating HIV/AIDS in Africa and saw the impact of medicine in places that need ...

CEO Vas Narasimhan said the company has more than 25 potential blockbusters in its pipeline. Psoriasis drug Cosentyx and heart failure drug Entresto are leading the charge among the company’s ...

Novartis’ new CEO Vas Narasimhan has said he wants to cut R&D costs by using digital tech, and has followed through by scaling up a virtual clinical trials collaboration with startup firm ...

Novartis’ new CEO Vas Narasimhan has shown his priorities by promoting the company’s digital chief to the executive committee. New broom and chief digital officer Bertrand Bodson has been ...

Vas Narasimhan, the CEO of Novartis, discusses the Swiss pharmaceutical company's first-quarter earnings. MAGA divided as Trump turns on Putin 'Trash' found deep inside a Mexican cave turns out to ...

"Even in this I think complex geopolitical environment, we feel confident we can deliver now this upgraded guidance," CEO Vas Narasimhan told CNBC's "Squawk Box Europe" on Tuesday. Sales continued ...

May 8, 2025 – Today, TIME reveals the second annual TIME100 Health list recognizing the 100 most influential individuals in ...

The patent expiries are a test of Chief Executive Officer Vas Narasimhan’s years-long overhaul of the company, with its focus narrowed to specific types of diseases. Last year Narasimhan first ...

Chief Executive Vas Narasimhan said on Monday. U.S. President Donald Trump last month flagged potential import duties of about 25% on pharmaceuticals as part of measures affecting a range of ...